We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Pathology

Image: Telomeres at the end of the chromosomes protecting against DNA deterioration (Photo courtesy of Dr. Daniel Friedland MD).

Chromosome Buffers Improve Understanding of Melanoma

Buffers that guard against damage to the ends of chromosomes could hold the key to a better understanding of malignant melanoma, the deadliest form of skin cancer.  More...
01 Oct 2014
Image: Histopathology of Breast Adenocarcinoma, × 20 magnification (Photo courtesy of Nikon).

Serum Protein Biomarkers Detect Invasive Breast Cancer

The ability of serum protein biomarkers in conjunction with autoantibodies to distinguish between invasive breast cancer and benign breast conditions has been demonstrated.  More...
01 Oct 2014
Image

Blood Test Identifies When Cancer Treatment Becomes Detrimental

Some treatments for prostate cancer, while initially effective at controlling the disease, not only stop working after a certain period of time but actually start driving tumor growth.  More...
29 Sep 2014

Noninvasive Prenatal Test Assesses Risk for Aneuploidies

A noninvasive prenatal test employs next-generation sequencing to assess risk for multiple fetal chromosomal aneuploidies from a single blood sample.  More...
28 Sep 2014
Image: Histopathology of cervical intraepithelial neoplasia (CIN3) showing severe dysplasia that spans more than 2/3 of the epithelium, and may involve the full thickness. This lesion may sometimes also be referred to as cervical carcinoma in situ (Photo courtesy of KGH/Wikipedia Commons).

Clinical Results Presented for Urine-Based High-Risk HPV Assay

Two pilot studies have demonstrated that a urine-based assay for the detection of high-risk human papillomavirus had high sensitivity for identifying women with high grade cervical intraepithelial neoplasia.  More...
24 Sep 2014
Image: The ACD RNAscope 2.0 Brown kit for in situ hybridization (Photo courtesy of Advanced Cell Diagnostics).

Blood Test for Receptor Predicts Prostate Cancer Treatment Response

Prostate cancer patients whose tumors contain a shortened receptor called androgen-receptor splice variant 7 messenger ribonucleic acid are less likely to respond to two widely used drugs for metastatic prostate cancer.   More...
21 Sep 2014
Image: The multiplex biomarker immunoassay platform (Photo courtesy of Aushon BioSystems).

Blood Test Offers Specific Treatment for Ovarian Cancer

A new blood test has been developed allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment.  More...
21 Sep 2014
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2025 Globetech Media. All rights reserved.